Celularity, Inc. (CELU) vs Serina Therapeutics, Inc. (SER)
- Celularity, Inc. CELU 1.25 −6.02%
- Serina Therapeutics, Inc. SER 1.77 −1.12%
Celularity, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. Celularity, Inc. and Serina Therapeutics, Inc. are of similar size ($45.5M and $43.2M). Celularity, Inc. grew revenue faster over the last twelve months: −62.8% against −94.2%. Serina Therapeutics, Inc. has the higher net margin (0.00% vs −375.9%) and the higher return on invested capital (0.00% vs −695.7%). Across the 17 metrics below, Celularity, Inc. leads on 9 and Serina Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | CELU | SER | Biotechnology median |
|---|---|---|---|
| Gross margin | 5.26% | 100.00% | 65.16% |
| Operating margin | (321.32%) | 0.00% | 0.00% |
| Net margin | (375.89%) | 0.00% | 0.00% |
| Free cash flow margin | (46.46%) | 0.00% | 0.00% |
| Return on equity | 349.83% | (306.22%) | (56.36%) |
| Return on assets | (62.45%) | (136.00%) | (48.04%) |
| Return on invested capital | (695.71%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack